Contraception, abortion, and pulmonary arterial hypertension;Contraception, interruption de grossesse et hypertension artérielle pulmonaire

Presse Medicale

Volumn 39, Issue SUPPL. 1, 2010, Pages

  Frachon, Irène ^a,b,c   Gaudin, Stéphanie Pozzi ^d   Jezequel, Catherine ^e   Jaïs, Xavier ^b,f   Gut Gobert, Christophe ^a,b,c   Christophe, Sandrine Roger ^b   Humbert, Marc ^b,f   Leroyer, Christophe ^a,b,c  

^a UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^b Universite de Brest   (France)

^c Groupe HTAP de Bretagne Occidentale Département de Médecine Interne et de Pneumologie   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e BREST UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ELLAONE; LEVONORGESTREL; PROGESTERONE; SPERMICIDAL AGENT; ULIPRISTAL ACETATE; UNCLASSIFIED DRUG;

ABORTION; AMENORRHEA; ARTICLE; BARRIER CONTRACEPTION; CONDOM; CONTRACEPTION; FEMALE STERILIZATION; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MATERNAL MORTALITY; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PULMONARY HYPERTENSION; REIMBURSEMENT; RELIABILITY; THERAPEUTIC ABORTION; TREATMENT CONTRAINDICATION; VASECTOMY; FAMILY PLANNING; FEMALE; GESTATIONAL AGE; HYPERTENSION, PULMONARY; MORTALITY; PATIENT SELECTION; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATIONS; PROCEDURES;

ABORTION, THERAPEUTIC; CONTRACEPTION; FAMILY PLANNING SERVICES; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION, PULMONARY; MATERNAL MORTALITY; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; STERILIZATION, REPRODUCTIVE;

EID: 77955945878     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(10)70007-5     Document Type: Article

References (11)

1. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., et al. Pulmonary arte rial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006, 173:1023-1030.
2. Bedard E., Dimopoulos K., Gatzoulis M.A. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?. Eur Heart J 2009, 30:256-265.
3. Prévenir les grossesses non désirées. Prescrire 2009;308:447-50.
4. Haute Autorité de Santé. Stratégies de choix des méthodes contraceptives chez la femme. Argumentaire, Décembre 2004. http://www.has-sante.fr/portail/jcms/c_272385/strategies-de-choix-desmethodes-contraceptives-chez-la-femme.
5. Sanchez O., Marié E., Lerolle U., Wermert D., Israël-Biet D., Meyer G. L'hypertension artérielle pulmonaire féminine. Rev Mal Respir 2008, 25:451-460.
6. Spence R., Mandagere A., Walker G., Dufton C., Boinpally R. Effect of steady-state ambrisentan on the pharmacokinetics of a single dose of the oral contraceptive norethindrone (norethisterone) 1 mg/Ethylestradiol 35 μg in healthy subjects. Clin Drug Investig 2010, 30:313-324.
7. Thorne S., Nelson-Piercy C., MacGregor A., Gibbs S., Crowhurst J., Panay N., Rosenthal E., Walker F., Williams D., de Swiet M., Guillebaud J. Pregnancy and contraception in heart disease and pulmonary hypertension. J Fam Plann Reprod Health Care 2006, 32:75-80.
8. Prager S., Darney P.D. The levonorgestrel intrauterine system in nulliparous women. Contraception 2007, 75:S12-S15.
9. Médecine et maladies infectieuses 2002, 32:542-552. Prophylaxie de l'endocardite infectieuse. Recommandations 2002 sous l'égide de Société de pathologie infectieuse de langue française.
10. Deanfield J., Thaulow E., Warnes C., Webb G., Kolbel F., Hoffman A. Management of grown up congenital heart disease. Eur Heart J 2003, 24:1035-1084.
11. Site Internet de l'association HTAP France: Dernier accès le 22 février 2010. http://www.htapfrance.com/public/informer/htap.htm.